Corporate actions
22 Nov 2024

Evotec: Takeover - terminated

On 22nd of Nov 2024: Halozyme Therapeutics Inc. announced today that they withdraw the intention to launch an offer for Evotec.

Due to this announcement the Futures will be set back to trading as of Monday, 25th of Nov 2024.


On 14 November 2024 after market close the company Halozyme Therapeutics Inc announced its proposal to acquire Evotec SE via a takeover offer to the shareholders of Evotec SE at a price of EUR 11.00 per share.

More information about this transaction is available on the companies` websites.

This information describes the potential effects this transaction will have on the above-mentioned contracts.


 

Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.